González Juan R, Peña Edsel A, Slate Elizabeth H
Cancer Prevention and Control Unit, Catalan Institute of Oncology, Avda. Gran via s/n, km. 2.7, Hospitalet de Llobregat 08907, Spain.
Stat Med. 2005 Dec 30;24(24):3959-75. doi: 10.1002/sim.2394.
This article addresses the problem of incorporating information regarding the effects of treatments or interventions into models for repeated cancer relapses. In contrast to many existing models, our approach permits the impact of interventions to differ after each relapse. We adopt the general model for recurrent events proposed by Peña and Hollander, in which the effect of interventions is represented by an effective age process acting on the baseline hazard rate function. To accommodate the situation of cancer relapse, we propose an effective age function that encodes three possible therapeutic responses: complete remission, partial remission, and null response. The proposed model also incorporates the effect of covariates, the impact of previous relapses, and heterogeneity among individuals. We use our model to analyse the times to relapse for 63 patients with a particular subtype of indolent lymphoma and compare the results to those obtained using existing methods.
本文探讨了将治疗或干预效果的信息纳入癌症复发模型的问题。与许多现有模型不同,我们的方法允许干预在每次复发后的影响有所不同。我们采用了佩尼亚和霍兰德提出的复发事件通用模型,其中干预的效果由作用于基线风险率函数的有效年龄过程来表示。为了适应癌症复发的情况,我们提出了一个有效年龄函数,该函数编码了三种可能的治疗反应:完全缓解、部分缓解和无反应。所提出的模型还纳入了协变量的影响、先前复发的影响以及个体之间的异质性。我们使用我们的模型分析了63例惰性淋巴瘤特定亚型患者的复发时间,并将结果与使用现有方法获得的结果进行了比较。